Document is current

Any future updates will be listed below

572 Fibroblast activating protein (FAP)-targeting IL-12 (anti-FAP/IL-12) TMEkine™ potentiates anti-cancer effects in preclinical cancer models

Crossref DOI link: https://doi.org/10.1136/jitc-2020-SITC2020.0572

Published Online: 2020-11-09

Published Print: 2020-11

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark